Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 5 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Adverum Biotechnologies Inc have a median target of 32.00, with a high estimate of 40.00 and a low estimate of 10.00. The median estimate represents a 456.52% increase from the last price of 5.75.
High | 595.7% | 40.00 |
Med | 456.5% | 32.00 |
Low | 73.9% | 10.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | +14.92% |
Average growth rate | -5.91% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -100.00% |
More ▼